Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Bloomage Biotechnology (688363.SS)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (Rmb) Price Target (Rmb) Rating
2022-03-30119.80164.44Neutral
2022-04-29135.50148.51Neutral
2022-08-31143.05151.58Neutral
2023-01-13130.01146.03Neutral
2023-06-1594.18100.60Neutral
2023-09-0192.8793.80Neutral
2023-10-3176.4684.72Neutral
2024-03-1263.7865.00Neutral
2024-05-0161.5061.70Neutral
2024-08-2649.0755.60Neutral
2024-11-0661.0061.50Neutral
2025-01-1650.3052.60Neutral

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.